Detail akcie USANA Hlth Sci online

Business Summary: USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
Financial Summary: BRIEF: For the nine months ended 27 September 2025, USANA Health Sciences Inc revenues increased 9% to $699.1M. Net income decreased 67% to $12.5M. Revenues reflect Americas and Europe segment increase of 85% to $74.2M. Net income was offset by Selling, general and administrative increase of 37% to $259.3M (expense), Interest income decrease of 78% to $1.9M (income). Basic Earnings per Share excluding Extraordinary Items decreased from $1.97 to $0.67.